ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,568 | +156.8% | 1,102 | +78.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 619 | +61800.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q4 2021 | $44,000 | -83.2% | 11,271 | -87.0% | 0.00% | – |
| Q2 2021 | $262,000 | -25.1% | 86,771 | -17.5% | 0.00% | – |
| Q1 2021 | $350,000 | +414.7% | 105,166 | +449.1% | 0.00% | – |
| Q4 2020 | $68,000 | -68.9% | 19,151 | -91.2% | 0.00% | – |
| Q1 2020 | $219,000 | -45.7% | 216,708 | +49.2% | 0.00% | – |
| Q4 2019 | $403,000 | +379.8% | 145,210 | +1169.8% | 0.00% | – |
| Q2 2018 | $84,000 | -92.3% | 11,436 | -93.5% | 0.00% | -100.0% |
| Q3 2017 | $1,092,000 | +72.2% | 176,091 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $634,000 | +10.8% | 176,000 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $572,000 | +32.7% | 176,001 | -0.0% | 0.00% | – |
| Q4 2016 | $431,000 | -29.3% | 176,080 | -0.7% | 0.00% | -100.0% |
| Q3 2016 | $610,000 | -0.5% | 177,260 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $613,000 | -15.7% | 176,270 | +0.1% | 0.00% | 0.0% |
| Q1 2016 | $727,000 | -7.4% | 176,150 | -0.0% | 0.00% | 0.0% |
| Q4 2015 | $785,000 | -29.1% | 176,231 | -3.0% | 0.00% | 0.0% |
| Q3 2015 | $1,107,000 | – | 181,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |